- Fred's Super Dollar: Pharmacy is key contributor to overall success
- Fred's paring its merchandising mix to favor pharmacy
- Fred's Super Dollar reports slight gains for November
- Fred's Super Dollar realizes 1.4% gain in fiscal 2013 sales to $1.9 billion
- Fred's Super Dollar reports March sales of $191.2 million, up 1%
MEMPHIS, Tenn. — Fred's Super Dollar on Thursday reported total sales of $159.2 million for the four weeks ended March 2, up some $200,000 from the corresponding year-ago period. Comparable store sales for the month declined 1.5%.
"Considering current economic headwinds, including delays encountered with processing tax returns and refunds as well as increased payroll taxes, we were pleased that February sales were within our projected range for the month," stated Bruce Efird, Fred's CEO. "General merchandise comparable store sales were positive for the second consecutive month, reflecting good momentum in new initiatives such as an expanded offering in auto/hardware and our discount tobacco shop. We also saw a solid start to our new spring layaway program, and while sales under this program are deferred until final payments are made and therefore not included in February, they would have added 60 basis points to the month's total and comparable store sales," he said. "In the pharmacy department, positive script growth continued, but as in previous months, top-line sales were negatively affected by the ongoing brand-to-generic shift. The effect of this shift on total and comparable store sales was 280 basis points in February."
Because of the combination of fourth quarter promotional markdowns on basic and consumable products, as well as year-end adjustments relating to higher-than-anticipated insurance and other operating costs, Fred's reduced its financial guidance for the fourth quarter of 2012. Fred's now expects to report earnings in the range of $0.16 to $0.21 per share for the fourth quarter.
During February, Fred's opened one new store and pharmacy location.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.